首页 > 市场调查报告书 > 医疗设备

体外诊断

移植诊断市场规模、份额和成长分析（按技术、产品和服务、应用、移植类型、最终用户和地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1897673

移植诊断市场规模、份额和成长分析（按技术、产品和服务、应用、移植类型、最终用户和地区划分）－2026-2033年产业预测

Transplant Diagnostics Market Size, Share, and Growth Analysis, By Technology (Molecular Assay Technologies, Pcr-Based Molecular Assays), By Product & Services, By Application, By Transplant Type, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月26日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，移植诊断市场规模将达到 48.7 亿美元，到 2025 年将达到 52.5 亿美元，到 2033 年将达到 95.8 亿美元，预测期（2026-2033 年）的复合年增长率为 7.8%。

移植诊断市场正经历强劲成长，这主要得益于器官移植需求的不断增长和诊断技术的持续进步。慢性疾病的普遍流行也推动了这一增长，而这些疾病往往会导致器官衰竭。随着对准确且高效的移植相容性检测需求的增加，预计该市场将进一步扩张，从而改善患者预后并提高移植成功率。一个值得关注的趋势是人工智慧 (AI) 和机器学习 (ML) 的融合。这些技术能够简化对包括基因组和临床资讯在内的海量资料集的分析，实现模式识别和相容性预测，从而优化器官分配。这些技术的应用有望显着提高移植诊断的准确性和效率，最大限度地利用资源并改善患者照护。

移植诊断市场驱动因素

末期肾功能衰竭、心臟衰竭和肝硬化等慢性疾病发生率的不断上升是推动器官移植需求的关键因素。这些严重的疾病往往需要透过器官移植来改善患者的生活品质和健康状况。此外，患者和医疗保健提供者对器官移植益处的认识不断提高，进一步加剧了对移植诊断的需求。对捐赠者相容性检测的日益重视，为该领域的进步创造了机会，最终推动了移植诊断市场的扩张，因为相关人员在寻求准确且高效的解决方案。

移植诊断市场限制因素

由于器官移植需求旺盛而合适器官供应有限，移植诊断市场面临巨大的限制。器官短缺导致患者等待移植的时间过长，增加了患者在等待期间的死亡风险和病情恶化。器官短缺不仅限制了移植手术的数量，也限制了相关诊断产品和服务的市场潜力。此外，不同地区关于器官捐赠的伦理问题、法律限制和文化态度进一步加剧了器官短缺，阻碍了移植诊断领域的发展。

移植诊断市场趋势

移植诊断产业的关键市场趋势是越来越多地整合先进技术，例如次世代定序（NGS），这正在改变供体和受体的配型方式。这种创新方法能够实现高通量基因分析，从而对人类白血球抗原（HLA）系统和其他重要的遗传标记进行全面分析。 NGS可以识别更广泛的HLA等位基因并发现罕见突变，从而提高配对准确性，并有助于做出更准确、更明智的移植决策。这项技术进步不仅简化了诊断流程，而且有望改善移植结果，最终降低移植物排斥的发生率，并最大限度地提高移植物长期存活率。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2021-2023年营收年比比较

主要企业简介

Abbott Laboratories（USA）
Bio-Rad Laboratories, Inc.（USA）
Thermo Fisher Scientific Inc.（USA）
Becton, Dickinson and Company（BD）（USA）
Omixon Ltd.（Estonia）
Hologic, Inc.（USA）
Immucor, Inc.（USA）
CareDx, Inc.（USA）
Qiagen NV（Netherlands）
BioGenuix, Inc.（USA）
F. Hoffmann-La Roche AG（Switzerland）
Fujifilm Holdings Corporation（Japan）
Eurofins Scientific SE（Luxembourg）
Genomatica, Inc.（USA）
Illumina, Inc.（USA）
Oxford Nanopore Technologies plc（UK）
Pacific Biosciences of California, Inc.（USA）
NanoString Technologies, Inc.（USA）
Fluidigm Corporation（USA）
Agilent Technologies, Inc.（USA）

结论与建议

简介目录

Product Code: SQMIG35A2553

Transplant Diagnostics Market size was valued at USD 4.87 Billion in 2024 and is poised to grow from USD 5.25 Billion in 2025 to USD 9.58 Billion by 2033, growing at a CAGR of 7.8% during the forecast period (2026-2033).

The Transplant Diagnostics market is experiencing robust growth, driven by heightened demand for organ transplantation and continuous advancements in diagnostic technologies. The prevalence of chronic diseases contributing to organ failures further fuels this growth. As the necessity for precise and efficient transplant compatibility testing escalates, the market is poised for further expansion, enhancing patient outcomes and transplant success rates. A notable trend is the integration of artificial intelligence (AI) and machine learning (ML), which streamline the analysis of extensive data sets, encompassing genomic and clinical information. These technologies enable the identification of patterns and prediction of compatibility, ultimately optimizing organ allocation. Their implementation promises to significantly improve the accuracy and efficiency of transplant diagnostics, thus maximizing resource utilization and patient care.

Top-down and bottom-up approaches were used to estimate and validate the size of the Transplant Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Transplant Diagnostics Market Segments Analysis

Global Transplant Diagnostics Market is segmented by technology, product & services, application, transplant type, end user and region. Based on technology, the market is segmented into molecular assay technologies, sequencing based molecular assays and non molecular assays technologies. Based on product, the market is segmented into reagents & consumables, instruments and software & services. Based on application, the market is segmented into diagnostic application and research applications. Based on transplant type, the market is segmented into solid organ transplantation, stem cell transplantation, soft tissue transplantation and bone marrow transplantation. Based on end user, the market is segmented into hospitals and transplant centers, research & academic institutes and independent reference laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Transplant Diagnostics Market

The increasing incidence of chronic illnesses, including end-stage renal disease, heart failure, and liver cirrhosis, is a significant factor contributing to the demand for organ transplants. These serious medical conditions frequently necessitate transplantation to enhance patients' quality of life and health outcomes. Additionally, rising awareness among patients and healthcare providers regarding the advantages of organ transplantation has further amplified the need for transplant diagnostics. This heightened focus on compatibility testing between donors and recipients has created opportunities for advancements in this field, ultimately driving the expansion of the transplant diagnostics market as stakeholders seek accurate and efficient solutions.

Restraints in the Transplant Diagnostics Market

The Transplant Diagnostics market faces significant restraints due to the imbalance between the high demand for organ transplants and the limited availability of suitable organs. This scarcity results in extended waiting lists for patients, heightening the risk of mortality or disease progression during the wait. The shortage of organs not only limits the number of transplant procedures but also constrains the market potential for related diagnostic products and services. Furthermore, ethical issues, legal regulations, and cultural attitudes towards organ donation in various regions further exacerbate the organ shortage, thereby hindering the growth and advancement of the transplant diagnostics sector.

Market Trends of the Transplant Diagnostics Market

A significant market trend in the transplant diagnostics industry is the growing integration of advanced technologies such as next-generation sequencing (NGS), which is transforming the landscape of donor-recipient matching. This innovative approach facilitates high-throughput genetic profiling, allowing for comprehensive analysis of the human leukocyte antigen (HLA) system and other critical genetic markers. NGS enhances precision in matching by identifying a broader spectrum of HLA alleles and unveiling rare variants, thus driving more accurate and informed transplant decisions. This technological advancement not only streamlines the diagnostic process but also holds the promise of improved transplant outcomes, ultimately reducing the incidence of graft rejection and maximizing long-term graft survival rates.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Transplant Diagnostics Market Size by Technology & CAGR (2026-2033)

Market Overview
Molecular Assay Technologies
- Pcr-Based Molecular Assays
- Real-Time Pcr
- Sequence-Specific Primer-Pcr
- Sequence-Specific Oligonucleotide-Pcr
- Other Pcr-Based Molecular Assays
Sequencing Based Molecular Assays
- Sanger Sequencing
- Next Generation Sequencing
- Other Sequencing Based Molecular Assays
Non Molecular Assays Technologies

Global Transplant Diagnostics Market Size by Product & Service & CAGR (2026-2033)

Market Overview
Reagents & Consumables
Instruments
Software & Services

Global Transplant Diagnostics Market Size by Application & CAGR (2026-2033)

Market Overview
Diagnostic Application
- Pre-Transplantation Diagnostics
- Infectious Disease Testing
- Histocompatibility Testing
- Blood Profiling
- Post -Transplantation Diagnostics
Research Applications

Global Transplant Diagnostics Market Size by Transplant Type & CAGR (2026-2033)

Market Overview
Solid Organ Transplantation
- Kidney Transplantation
- Liver Transplantation
- Heart Transplantation
- Lung Transplantation
- Pancreas Transplantation
- Other Organs Transplantation
Stem Cell Transplantation
Soft Tissue Transplantation
Bone Marrow Transplantation

Global Transplant Diagnostics Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals And Transplant Centers
Research & Academic Institutes
Independent Reference Laboratories

Global Transplant Diagnostics Market Size & CAGR (2026-2033)

North America (Technology, Product & Service, Application, Transplant Type, End User)
- USA
- Canada
Europe (Technology, Product & Service, Application, Transplant Type, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Technology, Product & Service, Application, Transplant Type, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Technology, Product & Service, Application, Transplant Type, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Technology, Product & Service, Application, Transplant Type, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (BD) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Omixon Ltd. (Estonia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Immucor, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CareDx, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qiagen N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioGenuix, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fujifilm Holdings Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific SE (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genomatica, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oxford Nanopore Technologies plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pacific Biosciences of California, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NanoString Technologies, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fluidigm Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments